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Alcohol use disorder (AUD) is a worldwide public health problem and a polygenetic
disorder displaying substantial individual variation. This work aimed to study individual
differences in behavior and its association to voluntary alcohol intake and subsequent
response to naltrexone in a seamless heterogenic group of animals. Thus, by this
approach the aim was to more accurately recapitulate the existing heterogeneity within
the human population. MaleWistar rats from three different suppliers (Harlan Laboratories
B.V., RccHanTM:WI; Taconic Farms A/S, HanTac:WH; and Charles River GmbH, Crl:WI)
were used to create a heterogenic group for studies of individual differences in
behavior, associations to intermittent voluntary alcohol intake and subsequent response
to naltrexone. The rats were tested in the open field prior to the Y-maze and then
given voluntary intermittent access to alcohol or water in the home cage for 6 weeks,
where after, naltrexone in three different doses or saline was administered in a Latin
square design over 4 weeks and alcohol intake and preference was measured. However,
supplier-dependent differences and concomitant skew subgroup formations, primarily
in open field behavior and intermittent alcohol intake, resulted in a shifted focus to
instead study voluntary alcohol intake and preference, and the ensuing response to
naltrexone in Wistar rats from three different suppliers. The results showed that outbred
Wistar rats are diverse with regard to voluntary alcohol intake and preference in a
supplier-dependent manner; higher in RccHanTM:WI relative to HanTac:WH and Crl:WI.
The results also revealed supplier-dependent differences in the effect of naltrexone that
were dose- and time-dependent; evident differences in high-drinking RccHanTM:WI rats
relative to HanTac:WH and Crl:WI rats. Overall these findings render RccHanTM:WI rats
more suitable for studies of individual differences in voluntary alcohol intake and response
to naltrexone and further highlight the inherent heterogeneity of the Wistar strain. The
overall results put focus on the importance of thoroughly considering the animals used
to aid in study design and for comparison of reported results.
Keywords: behavior, alcohol use disorder, Y-maze, open field, prefrontal cortex, spontaneous alternations, strain
variation, individual differences
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INTRODUCTION
Alcohol use disorder (AUD) is a worldwide public health
problem. Despite being a global problem, the approved
pharmacotherapy for AUD is restricted to a few substances
with varied and limited clinical efficacy (Nutt and Rehm, 2014).
Alcohol has a complex and still not fully understood mechanism
of action involving many different neurotransmitter systems
(Soderpalm and Ericson, 2013; Tabakoff and Hoffman, 2013;
Koob, 2014). One system of importance for the reinforcing effects
of alcohol and involved in the development of AUD is the
endogenous opioid system (Oswald andWand, 2004; Trigo et al.,
2010). In support of this, one of the substances approved for
treatment of AUD is the opioid receptor antagonist naltrexone,
exerting its effect by blocking the endogenous opioid receptors
and thereby the reinforcing effects of alcohol (O’Malley et al.,
1992; Volpicelli et al., 1992, 1995). However, a wide variation of
treatment effect has been reported and the body of research to
deduce the underlying reasons for these variations is numerous.
Age at alcohol drinking onset (Kranzler et al., 2003), level
of alcohol consumption (Mitchell et al., 2009), classification
based on typologies (Leggio et al., 2009), family history of
AUD (Garbutt et al., 2014), and genetic alterations (Oliva and
Manzanares, 2007; Palmer et al., 2013) have shown to play a
key role in the outcome of naltrexone treatment. Moreover, a
polymorphism in the µ-opioid receptor gene (Thorsell, 2013)
and early life environmental factors (Daoura andNylander, 2011)
impact on the response to naltrexone.
Animal experiments are a necessity to gain a deeper
understanding of the physiological, behavioral, and biochemical
processes of AUD (Crabbe, 2014), and variousmethods have been
developed to study these processes. Outbred animal strains are
generally preferred to more accurately recapitulate the existing
heterogeneity within the human population (Stewart and Kalueff,
2015). The Wistar rat is commonly used in AUD research
(Clause, 1993) and is the background for many selectively bred
alcohol-preferring lines. Although all Wistar rats originate from
the Wistar Institute in Philadelphia, generations of breeding at
different suppliers have made the Wistar rat diverge, e.g., with
regard to voluntary alcohol intake (Palm et al., 2011b; Goepfrich
et al., 2013) and differences in endogenous opioid peptide levels
(Palm et al., 2012), thus underlining the choice of supplier as an
important factor.
Wistar rats from different suppliers have previously been
characterized in the multivariate concentric square field™
(MCSF) test (Meyerson et al., 2006) and evident profile
differences were observed (Palm et al., 2011a). Moreover, we
recently showed that individual differences in risk-assessment
behavior were associated with differences in voluntary alcohol
intake, while no association between risk-taking behavior and
alcohol intake was found (Momeni et al., 2014). Risk-assessment
may relate to constructs of decision-making, and impaired
decision-making and cognitive dysfunction is associated with
excessive drug use (Balogh et al., 2013; Gowin et al., 2013).
Although the MCSF test is ethologically founded with the
purpose to enable behavioral profiling of the animal within
a single test situation to minimize risks of carryover effects
(Meyerson et al., 2006), possibilities for studies of specific
cognitive function are limited (Karlsson et al., 2009) and yet
not validated. Numerous studies have shown the relation of
generalized prefrontal cortex dysfunction, impaired cognitive
control, and excessive drug use (Goldstein and Volkow, 2011;
Bazov et al., 2013), and this area has also been studied to
understand mechanisms of compulsiveness and loss of control
and the propensity to self-administer drugs (Everitt and Robbins,
2005; George and Koob, 2010).
This work aimed to study individual differences in
spontaneous alternations in the Y-maze as indicative of
cognitive function (Lalonde, 2002) and its association to
voluntary alcohol intake and preference, and the subsequent
response to naltrexone. In order to create a seamless heterogenic
group of animals, representative of the heterogeneity among the
human population (Stewart and Kalueff, 2015) and, likewise,
among AUD patients (Hines et al., 2005), Wistar rats from three
different suppliers were included. In addition, the open field
(OF) test was used to control for potential differences in activity.
However, as we will show, the emerging data early on revealed
supplier-dependent differences of such magnitude that the aim
was shifted to instead focus on voluntary intake of alcohol and
the ensuing response to naltrexone. The concluding aim of
this paper is thus to behaviorally characterize Wistar rats from
three different suppliers in OF activity and Y-maze performance,
and thence study intermittent voluntary alcohol intake and
preference, and response to naltrexone treatment.
MATERIAL AND METHODS
Animals
A total of 60 outbred male Wistar rats, 20 rats from three
different suppliers, arrived at 8 weeks of age. The suppliers
used were Harlan Laboratories B.V., Horst, The Netherlands
(RccHan™:WI, referred to as Rcc), Taconic Farms A/S, Ejby,
Denmark (HanTac:WH, referred to as Tac) and Charles River,
GmbH, Sulzfeld, Germany (Crl:WI, referred to as Crl). The rats
were group-housed (2–3 rats/cage) in transparent polysulfone
cages (59 × 38 × 20 cm) containing wood chip bedding
material and two paper sheets (40 × 60 cm; Cellstoff, Papyrus)
as enrichment. The cages were placed in temperature- (21 ±
1◦C) and humidity-controlled (50 ± 10%) housing cabinets
with a reversed 12 h light/dark cycle (lights off at 07.00 h),
and masking background noise. The rats were maintained on
standard rat chow (R36; Lantmännen, Kimstad, Sweden) and
water ad libitum. All animal experiments were approved by the
Uppsala Animal Ethical Committee and followed the guidelines
of the Swedish Legislation on Animal Experimentation (Animal
Welfare Act SFS1998: 56) and the European Communities
Council Directive (86/609/EEC).
Experimental Procedure
An overview of the experimental procedure is shown in Figure 1.
The rats were allowed to acclimatize and reverse their light/dark
cycle for 2 weeks followed by 3 days of adaptation to experimental
procedures by handling in a procedure similar to that in previous
experiments (Roman et al., 2012). The rats were then tested in
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FIGURE 1 | The experimental outline. The rats were allowed to acclimatize to the animal facility and the reversed light/dark cycle for 2 weeks and adapted by daily
handling. Thereafter, the animals were tested in the open field (OF) followed by the Y-maze and then given intermittent access to alcohol and water in the home cage
on 3 consecutive days per week for 6 weeks. Subsequently, over the next 4 weeks naltrexone (NTX) and saline were administered in a Latin square design 30min
prior to alcohol access and intake was measured at 30min, 2 h, and 24 h.
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FIGURE 2 | Schematic illustration showing examples of (A) a correct and (B) an incorrect alternation in the Y-maze test, and (C) the level (%) of correct
alternations when comparing Wistar rats from different suppliers, i.e., RccHanTM:WI (Rcc), Crl:WI (Crl), and HanTac:WH (Tac). Data are presented as
mean ± SEM (ANOVA, Fisher’s LSD post-hoc test).
the OF followed by the Y-maze. The animals were then single
housed and given intermittent access to alcohol solution and
water in the home cage for 6 weeks. Subsequently, naltrexone in
three different doses or saline was administered in a Latin square
design over 4 weeks and alcohol intake was measured.
The Open Field Test
The OF consists of a black open and illuminated circular arena
(diameter 90 cm, 100 lx, Momeni et al., 2014). The animals were
started facing the wall and allowed to freely explore for 20min.
In the analysis, the arena is divided into three circular zones, i.e.,
center (30 cm in diameter), middle circle, and outer circle (each
15 cm wide). Time spent in the inner zone (merged middle circle
and center) is used for assessment of risk-taking behavior, thus
dividing the animals by central activity vs. thigmotaxis (Momeni
et al., 2014).
The Y-maze Test
The Y-maze is constructed of gray, non reflective plastic and
consists of three illuminated (100 lx) arms (zone A, B, and C)
each 50 cm long, 10 cm wide, and 20 cm high oriented at a 120◦
angle relative to each other with a central triangular area (mid
zone). The animals were started in arm A facing the mid zone
and allowed to freely explore for 10min. Alternation measures
the exploratory rotation of the animal and a correct alternation
is defined as the animal visiting all arms in a sequential fashion
without interruption in its arm choice, thus an alternation of for
example A to B to C is correct (Figure 2A) whereas A to B to A
is incorrect (Figure 2B), and the percent correct alternations is
the number of correct alternations divided by the total number
of alternations (Lalonde, 2002).
Behavioral Recordings
The animals were monitored from an adjacent room via a ceiling
mounted camera and visits to the defined zones were scored
on the premise that both hind legs were within the zone. The
latency (LAT, s) of first visiting a zone, frequency (FRQ) of
visits, and duration (DUR, s) of time spent in each zone, the
number of animals visiting each zone (occurrence, OCC), the
total distance (cm) traveled and the mean velocity (cm/s) in the
arenas were recorded. In addition, total duration (s) being mobile
and immobile, and number of correct and incorrect alternations
in the Y-maze were registered. All recordings and analyses
were made in the Ethovision system (version XT10 and macro
Sequence Analysis toolkit, Noldus Information Technology,
Wageningen, the Netherlands).
Voluntary Alcohol Intake
The animals were housed individually in cages (42 × 26 ×
18 cm) with wooden houses for enrichment, and alcohol was
introduced in a previously described intermittent two bottle free-
choice paradigm (Momeni and Roman, 2014) slightly modified
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from Wise (1973), Wayner et al. (1972), and Simms et al.
(2008). The animals were given 24 h access to two bottles, tap
water and 20% alcohol (v/v), for 3 consecutive days every week.
Bottle positions were changed each session to avoid placement
preference. Alcohol [diluted from 96% ethanol (Solveco Etanol A
96%; Solveco AB, Rosersberg, Sweden) in tap water] and water
were presented at room temperature in 150ml plastic bottles
with minimal spillage ball valve nipples (Scanbur AB, Sollentuna,
Sweden). During the days between the alcohol sessions the
animals had access to one bottle of water. Alcohol intake was
measured at the end of each 24 h session by weighing the bottles
and calculated as gram per kilogram. Alcohol preference was
calculated as alcohol intake (g) divided by total fluid intake (g).
To minimize disturbing factors during the intake measures the
cages were changed and animals weighed on a day with access to
water only.
Naltrexone Treatment
After 6 weeks of intermittent voluntary alcohol intake, naltrexone
treatment was initiated with three doses (0.03, 0.3, or 3mg/kg)
or saline based on previous studies (Daoura and Nylander, 2011;
Barson et al., 2013). Treatment was given in a Latin square
design so that, at the end, all animals had received all doses and
saline. Injections were given prior to the first alcohol session and
followed by two wash out sessions each week for 4 consecutive
weeks. Naltrexone (Sigma-Aldrich, Schenndorf, Germany) was
dissolved in saline and administered subcutaneously (Williams
and Broadbridge, 2009) at 1ml/kg 30min prior to alcohol access.
Alcohol intake, by bottle weighing, was measured at 30min, 2 h,
and 24 h after alcohol access and data presented as10-30,130-2,
and10-24, respectively.
Formation of subgroups
Subgroups were formed using a tertiary split of high,
intermediate and low, based on percentage duration in the inner
zone of the OF (Momeni et al., 2014), level of correct alternations
in the Y-maze, and alcohol intake prior to naltrexone (Momeni
and Roman, 2014). The tertiary split into high drinkers (HD),
intermediate drinkers (ID) or low drinkers (LD) (Momeni and
Roman, 2014) was based on alcohol intake during weeks 1–6 by
ranking all animals based on intake per week which was then
turned into a sum rank value over the 6 weeks of voluntary
intake. The tertiary split was done on all rats, collapsing across
supplier origin and then the percentage of rats from each supplier
falling into high, intermediate or low groups was calculated.
Statistical Analyses
Body weight data was normally distributed according to
the Shapiro-Wilk’s W-test; hence the parametric repeated
measurement analysis of variance (ANOVA) was used, followed
by the Fisher’s Least Significant Difference (LSD) post-hoc test.
Data collected from the behavioral recordings and fluid intake
did not show normal distribution according to the Shapiro-Wilk’s
W-test; hence non-parametric tests were used. For group analysis
of behavioral recordings and fluid intake, the non-parametric
Kruskal-Wallis test, followed by the Mann-Whitney U-test was
used. The Spearman Rank Order Correlation was used for
analysis of correlations of descriptive parameters in the OF and
Y-maze tests. To compare alcohol and water intake, and alcohol
preference over time during the period of naltrexone and saline
administrations the Friedman test followed by the Wilcoxon
matched pairs test was used. Interaction effects between supplier
and effects of naltrexone could not be tested due to the use
of non-parametric statistics. Statistica 12.0 (StatSoft Inc., Tulsa,
OK) was used for all statistical analyses, including skewness, and
differences were considered statistically significant at p ≤ 0.05.
RESULTS
Body Weight
Group-wise analysis of mean body weight weeks 1–6 with
alcohol access prior to naltrexone treatment revealed higher body
weight in age-matched Crl rats relative to Rcc and Tac animals
throughout, whereas no differences were found between Rcc and
Tac animals (Supplementary Figure 1).
The Open Field Test
In general, differences were found comparing Crl rats with Rcc
and Tac rats. Specifically all parameters concerning activity and
exploratory behavior, and percentage duration in the inner zone
were higher in Crl rats (Supplementary Table 1). An overall
correlation between the latter parameter and total activity was
found (ρ= 0.89, p < 0.0001) in all rats, and within the respective
group; Rcc (ρ = 0.80, p < 0.0001), Crl (ρ = 0.82, p < 0.0001),
and Tac (ρ= 0.87, p < 0.0001).
The Y-maze Test
No differences between groups were found comparing the
percentage correct alternations (Figure 2C). Crl rats displayed
increased mobility and longer total distance traveled compared
to Rcc and Tac, while no differences between Rcc and Tac were
found. Analysis of time spent in the arms (zone A, B, or C)
revealed no differences and the pattern of alternation was similar
for all groups, but Crl spent more time in the mid zone relative
to the others (Supplementary Table 2). An overall correlation was
found between total distance moved in the OF and the Y-maze
(ρ= 0.58, p < 0.0001), but without correlations within groups.
Alcohol Intake and Preference Prior to
Naltrexone Treatment
Voluntary alcohol intake was studied using the modified
intermittent paradigm with alcohol access for 3 consecutive days
per week (Momeni and Roman, 2014). Overall differences were
found for week 1 (H = 16.12; p < 0.001) and 4 (H = 6.11;
p < 0.05) with the highest intake in the Rcc group (Figure 3A).
An increase in voluntary alcohol intake over the 6 weeks of
access was observed when analyzing all animals (χ2 = 44.75;
p < 0.0001), but also Crl (χ2 = 30.54; p < 0.0001) and Tac
(χ2 = 18.89; p < 0.05) separately, but not in Rcc. The median
and quartile range (QR) of alcohol intake (g/kg) week 6 was: Rcc
2.7 (2.0–4.5), Crl 2.3 (1.8–2.8), and Tac 2.2 (1.7–2.6).
Differences in intake upon regaining alcohol access (drinking
day 1 each week) compared to when accustomed (drinking day
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FIGURE 3 | Weekly voluntary alcohol intake (g/kg, A), average alcohol intake (g/kg) on the 3 days of access (drinking day 1, 2, and 3, B), and alcohol
preference (%, C) during the 6 weeks of intermittent access prior to naltrexone treatment in Wistar rats from three different suppliers, i.e.,
RccHanTM:WI (Rcc), Crl:WI (Crl), and HanTac:WH (Tac). Data are shown as median with shaded areas indicating min and max (A,C), and median and quartile
range (B). Cp ≤ 0.05, CCp < 0.01, CCCp < 0.001 compared to Crl rats, Tp = 0.05 and TTTp < 0.001 compared to Tac rats (Mann-Whitney U-test), 1p = 0.05,
11p < 0.01, 111p < 0.001 compared to the intake on drinking day 1 within the respective group, and 2p = 0.05, 22p < 0.01, 222p < 0.001 compared to the intake on
drinking day 2 within the respective group (Wilcoxon matched pairs test).
3) were assessed by comparing the average intake for drinking
days 1, 2, and 3 (Figure 3B). Group-wise comparisons revealed
a higher alcohol intake in Rcc on drinking day 1 and 3, with a
tendency toward significance (p = 0.07) on day 2, compared to
Tac, and drinking day 1 and 2 compared to Crl. The intake within
groups showed an evident pattern in Rcc with the highest intake
on day 1 relative to 2 and 3, whereas in Crl and Tac the pattern
was less pronounced but both still had the highest intake on day
1 (Figure 3B).
Overall differences in alcohol preference (%) between groups
were found for all weeks except 2 and 3. Post-hoc analysis revealed
a higher preference in Rcc compared to Tac week 1 and 4, and
compared to Crl for all weeks except 2 and 3. At week 6, alcohol
preference was higher in Tac relative to Crl (Figure 3C).
Water and Total Fluid Intake Prior to
Naltrexone Treatment
Overall differences were found in water intake for all weeks
except 1 and 3, and in total fluid intake for all weeks except 1
and 2 (Supplementary Tables 3A,B). Post-hoc analysis revealed a
higher water intake in Crl compared to Rcc (weeks 2 and 4–6) and
Tac (week 4–6), and a higher total fluid intake in Crl compared to
Rcc and Tac (week 4–6 and 3–6, respectively).
Formation Of Subgroups
No correlations were found between OF or Y-maze behavior and
voluntary alcohol intake (data not shown). The overall skewness
for duration in the inner zone of the OF was 1.1 and alcohol load
week 6 was 1.6, whereas the level of correct alternations in the Y-
maze were more evenly distributed. A skewed pattern was found
also within the respective supplier group (Table 1). This finding
led to the rejection of the original hypothesis, which was creating
subgroups based on an assumed seamless heterogeneity among
animals from different suppliers.
Alcohol intake within each supplier group after a tertiary into
HD, ID, and LD subgroups is shown in Figure 4. Rcc showed a
large variation in alcohol intake prior to naltrexone treatment
TABLE 1 | Formation of subgroups.
Rcc Crl Tac
OPEN FIELD
High 30% 60% 10%
Intermediate 30% 30% 40%
Low 40% 10% 50%
Skewness 0.5 0.8 0.8
Y-MAZE
High 35% 25% 40%
Intermediate 35% 35% 25%
Low 30% 40% 35%
Skewness 0.1 −0.8 −0.1
ALCOHOL INTAKE
High 65% 15% 20%
Intermediate 20% 40% 40%
Low 15% 45% 40%
Skewness 1.0 0.7 −0.6
Formation of subgroups based on a tertiary split of percentage duration in the inner zone
of the OF, level of correct alternations in the Y-maze and voluntary alcohol intake prior to
naltrexone in Wistar rats from three different suppliers, i.e., RccHanTM :WI (Rcc), Crl:WI
(Crl), and HanTac:WH (Tac). Data are presented as the distribution of animals from a
tertiary split into groups of high, intermediate and low for each parameter.
as a difference was found between HD and LD for all weeks of
access, between HD and ID except for week 2, and ID and LD
except weeks 1–2 (Figure 4A). For Crl, a difference was found
between HD and LD for weeks 4–6 and between HD and ID for
week 4 (Figure 4B). In Tac, a difference was found between HD
and LD and between ID and LD for weeks 3–6 (Figure 4C). With
regard to alcohol preference during week 6, Rcc-HD displayed
higher preference compared to ID and LD but no difference
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FIGURE 4 | Voluntary alcohol intake (g/kg) prior to naltrexone in Wistar
rats from three different suppliers, i.e., RccHanTM:WI (Rcc, A), Crl:WI
(Crl, B), and HanTac:WH (Tac, C), divided by a tertiary split into high
drinkers (HD), intermediate drinkers (ID) and low drinkers (LD) based
on alcohol intake during weeks 1-6. Data are shown as median. *p ≤ 0.05,
**p < 0.01, ***p < 0.001 compared to the respective LD group; #p ≤ 0.05,
##p < 0.01 compared to the respective ID group (Mann-Whitney U-test).
was found comparing Rcc-ID and Rcc-LD. Crl-HD and ID had
higher preference compared to Crl-LD, but no difference was
found comparing Crl-HD and ID. Similarly, Tac-HD and ID had
higher preference compared to Tac-LD, but no difference was
found comparing Tac-HD and ID (data not shown).
The Effect of Naltrexone on Alcohol Intake
and Preference
The Effect of Naltrexone on Alcohol Intake and
Preference after 30min
An overall effect of naltrexone on alcohol intake was found in all
rats 30min after alcohol access, and dose-dependent differences
were observed when comparing all doses of naltrexone to saline
(Figure 5A). Group-wise comparisons showed an overall effect
within each group. All three doses of naltrexone reduced alcohol
intake compared to saline in Rcc, but no intra-dose differences
were observed between the two highest doses. A dose-dependent
effect of naltrexone on alcohol intake was seen in Crl, and a
general but not dose-dependent effect in Tac (Figure 5A).
When analyzing all rats, no overall effect of naltrexone on
alcohol preference was found 30min after alcohol access, or any
differences within each supplier group (data not shown).
The Effect of Naltrexone on Alcohol Intake and
Preference after 2 h
An overall effect of naltrexone on alcohol intake was found in all
rats 2 h after alcohol access, and naltrexone at 0.3 along with 3 but
not 0.03mg/kg resulted in decreased alcohol intake compared to
saline in all rats (Figure 5B). Group-wise comparisons revealed
an overall effect of naltrexone on alcohol intake in Rcc and
Tac, while a different pattern was observed in Crl. In Rcc, a
decrease in intake was found after naltrexone at 0.3 and 3 but
not after 0.03mg/kg. An effect of naltrexone on alcohol intake
after all doses compared to saline was found in Tac, but no
dose-dependent effect. In Crl, no decrease in alcohol intake
compared to saline was found for any dose. Moreover, naltrexone
at 0.03mg/kg resulted in a higher intake compared to 0.3 and
3mg/kg (Figure 5B).
When analyzing all rats, no overall effect of naltrexone on
alcohol preference was found in all rats 2 h after alcohol access,
or any differences within each supplier group (data not shown).
The Effect of Naltrexone on Alcohol Intake and
Preference after 24 h
After 24 h a minor effect of naltrexone on alcohol intake
(Figure 5C) and preference (data not shown) was seen, where
naltrexone at 0.3mg/kg reduced the intake and preference for all
rats but there were no differences within each supplier group.
The Effect of Naltrexone on Alcohol Intake and
Preference in High-, Intermediate-, and Low-drinking
Animals
The response to naltrexone on alcohol intake after 30min
in HD, ID, and LD subgroups within each supplier group is
shown in Figure 6A. In Rcc-HD, all three doses of naltrexone
reduced alcohol intake compared to saline, but no intra-dose
differences were observed between the two highest doses. In
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FIGURE 5 | Voluntary alcohol (A–C) and water (D–F) intake (g/kg) after treatment with saline or naltrexone (0.03, 0.3, or 3mg/kg) administered s.c.
30min prior to alcohol access in Wistar rats from three different suppliers, i.e., RccHanTM:WI (Rcc), Crl:WI (Crl), and HanTac:WH (Tac). Alcohol and
water intake was measured at 30min (A,D, respectively), 2 h (B,E, respectively), and 24 h (C,F, respectively) after access. Data are presented as median and quartile
range. *p ≤ 0.05, **p < 0.01, ***p < 0.001 compared to saline; @p ≤ 0.05, @@p < 0.01, @@@p < 0.001 compared to naltrexone at 0.3mg/kg; #p ≤ 0.05,
##p < 0.01, ###p < 0.001 compared to naltrexone at 3mg/kg (Wilcoxon matched pairs test).
Rcc-LD, naltrexone at 0.03 and 0.3mg/kg resulted in lower
alcohol intake, while no effect of naltrexone was found in
Rcc-ID. In Crl, all groups responded to naltrexone compared
to saline, except at 0.03mg/kg in Crl-HD, and 0.3 in Crl-
LD. In Tac, naltrexone at 0.03 and 3mg/kg resulted in lower
alcohol intake compared to saline in HD, whereas no effect
was seen for ID or LD (Figure 6A). No effect of naltrexone on
alcohol intake was seen 2 or 24 h after alcohol access (data not
shown).
The response to naltrexone on alcohol preference after
30min in HD, ID, and LD subgroups within each supplier
group is shown in Figure 6B. In Rcc-HD, naltrexone at
3mg/kg reduced alcohol preference compared to saline
and naltrexone at 0.03mg/kg. In Rcc-LD naltrexone at
3mg/kg resulted in increased preference relative to 0.03
and 0.3mg/kg; this effect remained also after 2 h. In Rcc-
ID, as well as in Crl and Tac subgroups, no effect of
naltrexone on alcohol preference was seen after 30min
(Figure 6B) or after 2 h (data not shown). After 24 h
some effects on alcohol preference were found. In Crl-
ID there was a decrease in preference between saline and
naltrexone at 0.03mg/kg and an increased preference following
naltrexone at 3mg/kg compared to each of the two lower
doses. In Rcc-ID there was a decreased preference following
naltrexone at 0.3 compared to 3mg/kg, and decreased in
Rcc-LD following naltrexone at 0.03 compared to 3mg/kg
(data not shown).
The Effect of Naltrexone on Water Intake
The Effect of Naltrexone on Water Intake after 30min
An overall effect of naltrexone on water intake was found in
all animals after 30min, and group-wise comparisons revealed
an overall effect of naltrexone compared to saline in Tac, a
less pronounced effect in Crl, and no effect in Rcc. Specifically,
naltrexone at 0.3 and 3mg/kg decreased water intake compared
to 0.03mg/kg in Crl (Figure 5D).
The Effect of Naltrexone on Water Intake after 2 h
An effect of naltrexone at 0.3 and 3mg/kg on water intake was
found in all animals after 2 h. Group-wise comparisons revealed
an overall effect of naltrexone compared to saline in Tac, and
a less pronounced effect in Rcc and Crl. In Rcc, a decreased
intake compared to saline was found following naltrexone at
0.3 and 3mg/kg, whereas in Crl an increased water intake
after naltrexone at 0.03mg/kg compared to saline was found
(Figure 5E).
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FIGURE 6 | Voluntary alcohol intake (A) and preference (B) after treatment with saline or naltrexone (0.03, 0.3, or 3mg/kg) administered s.c. 30min
prior to alcohol access in Wistar rats from three different suppliers, i.e., RccHanTM:WI (Rcc), Crl:WI (Crl), and HanTac:WH (Tac), divided by a tertiary
split into high drinkers (HD), intermediate drinkers (ID), and low drinkers (LD) based on the alcohol intake during weeks 1–6. Data are presented as
median and quartile range. *p ≤ 0.05 compared to saline; @p ≤ 0.05 compared to naltrexone at 0.3mg/kg; #p ≤ 0.05 compared to naltrexone at 3mg/kg (Wilcoxon
matched pairs test).
The Effect of Naltrexone on Water Intake after 24 h
A minor, but still significant, effect of naltrexone on water
intake was found in all animals after 24 h, and group-wise
comparisons revealed an effect of naltrexone compared to
saline in Crl and Tac, but not in Rcc. More precisely, water
intake decreased in Tac and Crl after naltrexone at 3mg/kg
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compared to saline, and compared to 0.03 and 0.3mg/kg
(Figure 5F).
DISCUSSION
This study aimed to investigate individual differences in behavior,
its association to voluntary alcohol intake, and the subsequent
response to naltrexone on voluntary alcohol intake in a
heterogeneous group ofWistar rats, composed bymixing animals
from different suppliers. The rationale for this study design is the
recently highlighted limited concordance of animal experiments
with subsequent human clinical trials, which urgently warrants
progress in the translational value of preclinical data (Howells
et al., 2014; Everitt, 2015). Thus, full control and detailed
knowledge of the experimental models used are a prerequisite
to both understand the pathophysiology of complex human
disorders and in the development of novel treatment strategies
(Stewart and Kalueff, 2015).
Behavioral Responses, Voluntary Alcohol
Intake, and Rejection of Original
Hypothesis
Analysis of data (OF, Y-maze, and voluntary alcohol intake)
revealed supplier-dependent differences and concomitant skew
subgroup formations of such magnitude that the direction of
the study needed to be changed. The differences, primarily
in OF performance and voluntary alcohol intake, were of a
supplier-dependent origin rather than equally distributed in the
heterogeneous group (Table 1). Subgroup formations based on
OF behavior were skewed as the Crl animals were more active,
in line with previous studies in our group (Palm et al., 2011a),
and had the highest percentage duration in the inner zone, i.e.,
risk-taking behavior (Momeni et al., 2014), compared to Tac
and Rcc rats. No association between risk-taking behavior in
the OF and voluntary alcohol intake was found, in line with
previous results (Momeni et al., 2014), and subgroup formations
based on the analysis of correct alternations in the Y-maze were
more evenly distributed. The MCSF test has previously been
used for assessment of cognitive performance (Karlsson et al.,
2009), however, detailed measures of this need further validation.
Compared to other tests used for assessment of cognitive
function spontaneous alternations in the Y-maze is based on
an innate response and does not require extensive training of
animals, which is advantageous in the study design used. Signs
of neuroadaptation and changes in cognitive ability, measured
as choice behavior in the Y-maze and spontaneous alternations,
have shown to be influenced by prefrontal cortex (Pickering
et al., 2015) rather than hippocampal function (Lalonde,
2002). Intermittent exposure to alcohol resulted in impaired
Y-maze performance as assessed by spontaneous alternations
(Gotesson et al., 2012), whereas this study was designed to
assess a potential association between individual differences in
spontaneous alternation patterns in the Y-maze and voluntary
alcohol intake, which could not be found (data not shown).
In addition, subgroup formation by a tertiary split based on
voluntary alcohol intake prior to naltrexone treatment revealed
a skewed distribution as the Rcc animals had notably higher
alcohol intake compared to Tac and Crl rats, in agreement with
Palm et al. (2011b) and Goepfrich et al. (2013). In summary, the
primary aim of creating a seamless heterogenic group of outbred
animals using Wistar rats from different suppliers for studies of
individual predisposed differences in behavior and associations
with voluntary alcohol intake was abandoned. Therefore, the aim
was shifted to focus on voluntary alcohol intake and the ensuing
response to naltrexone in outbred Wistar rats from different
suppliers.
Alcohol Intake and Preference Prior to
Naltrexone Treatment
Primarily, data presented herein show that outbred Wistar rats
differ with regard to voluntary alcohol intake in a supplier-
dependent manner. The Rcc group displayed the highest alcohol
intake and preference, which also is supported by previous
studies (Palm et al., 2011b; Goepfrich et al., 2013), and the
level of voluntary alcohol intake in the Rcc group, using the
same intermittent two-bottle model, is also replicated from
a previous study in our lab (Momeni and Roman, 2014).
Notably, the alcohol intake patterns differed somewhat between
the Wistar groups. Rcc rats exhibited a stabile intake that
peaked more or less upon initial access, which has been shown
previously (Palm et al., 2011b; Goepfrich et al., 2013; Momeni
and Roman, 2014), while Crl and Tac rats showed an initial
increase followed by stabilization (Palm et al., 2011b). The lack of
a pronounced escalation in intake was similar to previous reports
on intermittent access paradigms (Adermark et al., 2011; Palm
et al., 2011b; Suchankova et al., 2013; Momeni and Roman, 2014;
Momeni et al., 2014), but in contrast to others (Carnicella et al.,
2014).
Comparing intake on the days of alcohol access, i.e., drinking
days, the Rcc group displayed increased intake on drinking day
1 relative to day 2 or day 3, which implies an alcohol deprivation
effect as previously observed (Momeni and Roman, 2014), while
not as distinct in the Tac and Crl groups.
Pronounced subgroup-dependent differences were found
upon a tertiary split of the respective Wistar groups into HD,
ID, and LD based on voluntary alcohol intake week 1–6 prior
to naltrexone treatment. Individual differences were particularly
apparent in Rcc rats, thus confirming previous findings (Momeni
and Roman, 2014) and in agreement with others (Steensland
et al., 2012; Fredriksson et al., 2015). Rcc-HD animals differed
from all other groups by a consistently higher intake during all 6
weeks, whereas Rcc-ID/LD animals more closely resembled Crl
and Tac rats.
Condensed, these data in our view render the Rcc rats
more suitable for studies of voluntary alcohol intake, especially
regarding individual differences, than Crl and Tac rats.
The Effect of Naltrexone on Alcohol Intake
and Preference
The doses of naltrexone used were based on previous studies
(Daoura and Nylander, 2011; Barson et al., 2013) and enabled a
detailed assessment of dose-dependent responses in the different
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groups. Examining the data as one heterogeneous group, i.e., in
all rats, a dose-dependent response to naltrexone was revealed.
The effect of naltrexone compared to saline was seen following all
doses as early as 30min after alcohol access, and still evident in
the highest doses (0.3 or 3mg/kg) after 2 h. This is in agreement
with others using similar doses of naltrexone at 30min (Simms
et al., 2008; Daoura and Nylander, 2011) and 2 h (Daoura and
Nylander, 2011) after alcohol access.
Supplier-dependent differences in the effect of naltrexone
were observed, as the effect was discontinued in Crl rats and only
observed for the two highest doses in Rcc rats at 2 h. An overall
effect was seen for all doses in Tac rats at 2 h, and the effect had
ceased in all groups 24 h after access. It can not be excluded that
the lack of dose dependent effects of naltrexone in the Tac group
is due to a floor effect (Cichelli and Lewis, 2002). Others report
that naltrexone at 0.02mg/kg decreased alcohol intake after 2 h
in a subgroup of Sprague-Dawley rats displaying high novelty-
induced activity (Barson et al., 2013), which may resemble the
Crl rats studied here with high OF activity and loss of naltrexone
effect at 2 h. In line with the present results, naltrexone at 1 and
2mg/kg decreased alcohol intake 4 h after alcohol access in Rcc
rats (Steensland et al., 2012; Fredriksson et al., 2015).
Assessing naltrexone effects at 30min in HD, ID and LD
groups reveled that Rcc-HD animals stand out with a combined
dose-dependent decrease in alcohol intake and a decrease in
alcohol preference following the highest dose, not evident in the
Rcc-ID or LD animals or any other supplier subgroup. The effect
in the Rcc-HD group can be attributed to increased intake in
this subgroup, as previous studies describe a more striking effect
of naltrexone in individuals with a high level of alcohol intake
(Mitchell et al., 2009). Also, naltrexone at 1 and 2mg/kg reduced
alcohol intake in Rcc rats with a similar intermittent voluntary
alcohol intake as herein (Steensland et al., 2012; Fredriksson
et al., 2015). Furthermore, naltrexone was more effective in
reducing voluntary alcohol intake in animals subjected to rearing
conditions simulating an unsafe early life environment and
concomitant higher adult voluntary alcohol intake (Nylander and
Roman, 2013) relative to a simulated protective environment
(Daoura and Nylander, 2011).
In addition to the effects of naltrexone on alcohol intake,
Rcc-HD animals stand out with a decrease in alcohol preference
following the highest dose, which further supports its efficacy in
certain subgroups (Mitchell et al., 2009) and adds to the results
following administration of the opioid antagonist naloxone
(Cichelli and Lewis, 2002). In contrast, in the Rcc-LD group
naltrexone at 3mg/kg resulted in increased preference. This
finding is in agreement with a previous study in which naltrexone
administration resulted in increased preference for 20% alcohol
in animals reared in a more beneficial early life environment
with concomitant lower adult voluntary alcohol intake (Daoura
and Nylander, 2011; Nylander and Roman, 2013) and consistent
with an increased alcohol intake after naltrexone in individuals
with no family history of AUD (Krishnan-Sarin et al., 2007). No
effect of naltrexone on preference was seen in Rcc-ID animals
or any other supplier subgroup. Thus, the impact of naltrexone
on alcohol preference in addition to its effects on water intake
(see below) renders some of the effects questionable; this may
partly be due to a floor effect as previously proposed (Cichelli
and Lewis, 2002) or explained by the low/moderate level of
alcohol intake in the Rcc-ID group as well as the Crl and Tac
subgroups.
The Effect of Naltrexone on Water Intake
In all rats as a heterogeneous group, a dose-dependent response
to naltrexone on water intake was found at 30min, which also
was evident for the two highest doses at 2 h. Moreover, there
were supplier-dependent differences in the effect of naltrexone
on water intake, which were dose- and time-dependent. In Tac
rats there was a general effect of naltrexone on water intake at
30min and 2 h, whereas in Rcc rats there was no effect at 30min
but of the two highest doses at 2 h. In contrast, the Crl rats had
an unclear effect at 30min and the lowest dose resulted in an
increased water intake at 2 h. Previous reporting on the effects of
naltrexone on water intake is sparse, and findings in the literature
are also inconsistent. Studies report on its particular effect on
alcohol intake and absent effect on water intake (Daoura and
Nylander, 2011; Barson et al., 2013), attenuated fluid intake in
general, including water (Lang et al., 1982; Escher andMittleman,
2006; Simms et al., 2008; Steensland et al., 2012), and some do not
present data on water intake, thereby making the understanding
of exact mechanisms and effects of naltrexone difficult to dissect.
It is well-established that the opioid system is also involved in
regulating appetite control and general ingestion (Reid, 1985;
Cichelli and Lewis, 2002), which can in part explain the non-
alcohol specific effects of naltrexone.
General Discussion
Discussions about the most appropriate experimental design
centers on the pivotal question of maximizing or minimizing
variance by using outbred or inbred animals and the strict use
of constant controlled conditions. From a population validity
point of view it has been argued that the use of heterogeneous
outbred animals is advantageous for translatability into human
disorders, especially upon division into subgroups for studies
of individual differences, responders and non-responders etc.
(Stewart and Kalueff, 2015). We here attempted to create a
seamless heterogenic group by mixing Wistar rats from different
suppliers to be divided into subgroups based on individual
differences in behavior, voluntary alcohol intake, and subsequent
response to pharmacologic treatment. However, due to the
skewed distribution of animals related to supplier origin, this
was impossible. On the contrary, by comparing Wistar rats
from the different suppliers we were able to replicate data from
previous studies (Daoura and Nylander, 2011; Palm et al., 2011b;
Goepfrich et al., 2013; Momeni and Roman, 2014; Momeni
et al., 2014). Most researchers are aware that differences between
rat strains and lines from different suppliers exist. However,
there are surprisingly few articles on this topic, especially
considering how important the awareness of such differences is
when selecting the appropriate animals for testing experimental
hypotheses as well as for comparison of results between studies.
In recent years, systematic studies on this topic have been
conducted (Palm et al., 2011a,b, 2012; Goepfrich et al., 2013)
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that hopefully will increase future interest in this field of
research.
Considering alcohol’s complex and yet not fully understood
mechanism of action (Soderpalm and Ericson, 2013; Tabakoff
and Hoffman, 2013; Koob, 2014) it is difficult to speculate
about underlying causes for the results presented herein.
Antecedent studies on Wistar rats from different suppliers
revealed differences in opioid peptide levels, both basal and
alcohol-induced, which also correlated to voluntary alcohol
intake (Palm et al., 2012). As the opioid system is highly relevant
for regulating alcohol intake (Oswald and Wand, 2004; Trigo
et al., 2010) and the concomitant effect of naltrexone (Volpicelli
et al., 1992; Thorsell, 2013), individual differences in the opioid
system (Oswald andWand, 2004) may play a role. The presented
results on voluntary alcohol intake and preference reflect the
current literature, where wide variations in intake are reported
among drinking paradigms (Crabbe et al., 2010; Becker, 2013;
Carnicella et al., 2014), and pinpoints important factors for
consideration.
Generally, the findings herein indicate that the heterogeneity
of Wistar rats can offer advantages to translational research.
Although AUD is diagnosed by diagnostic criteria, which
evaluate several aspects of the disorder, this patient group
displays great heterogeneity (Hines et al., 2005; Leggio et al.,
2009). For instance, naltrexone shows a good overall effect in
humans but when studying the population in subgroups there
are obvious differences (Thorsell, 2013). The confirmation of a
wide heterogeneity within the Wistar rat and the possibility for
detailed studies of subgroups adds pieces of understanding to the
puzzle of different pharmacological responders.
CONCLUSION
In search of individual differences in this study, multiple
methodologies were used; behavioral assessment, voluntary
alcohol consumption, and pharmacological intervention. The
major finding is that the voluntary alcohol consumption and the
concomitant response to naltrexone are different in commonly
used Wistar rats from different suppliers. In addition, there
are differences in the behavior of animals from the different
suppliers in the OF, and to a less extent in the Y-maze, that
adds to the complexity of individual differences vs. supplier-
dependent effects. The condensed data, in our view, render
the Rcc Wistar rats more suitable for studies of individual
differences in voluntary alcohol intake and preference, and
response to pharmacological treatment; this due to an increased
alcohol intake, similar to an alcohol deprivation effect, when
regaining alcohol using intermittent access, and the presence of
a distinguishable high-drinking subpopulation with increasing
alcohol intake over time and pronounced effects of naltrexone
on alcohol intake and preference. Finally, it is the ambition
of the authors that the results presented herein will aid in
understanding the sometimes large variation and discrepancy
reported, and that it can be used henceforth to aid in study design
and for comparison of reported results. The overall results put
focus on the importance of thoroughly considering the animals
used in future research and acknowledge the fact that “a Wistar
rat is not just any Wistar rat.”
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